Literature DB >> 30600135

Physicians' and Nurses' Attitudes and Actions Regarding Perioperative Medication Management.

Susanne Winther Olsen, Eva Draborg, Marianne Lisby.   

Abstract

PURPOSE: To investigate physicians' and nurses' attitudes and actions related to the prescription and administration of perioperative antibiotics and opioids during a 2-week period.
DESIGN: A quantitative descriptive and analytical research design performed at a Danish University Hospital.
METHODS: An email survey using an 18-item questionnaire was sent to 163 nurses and physicians involved in the perioperative period.
FINDINGS: Of 163 participants, 114 (69.9%) returned the questionnaire. Between 12% and 29% of the respondents reported that they did not correctly manage the medication, although they thought it to be important. Between 41% and 68% of the respondents experienced incorrect medication management with significant differences among professions and specialties.
CONCLUSIONS: The study confirms a knowing-doing gap in medication management in perioperative settings, highlighting the need to address this issue, to ensure that physicians and nurses act in accordance with their beliefs and consider the importance of medication safety in interdisciplinary work across specialties.
Copyright © 2018 American Society of PeriAnesthesia Nurses. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adverse drug events; attitudes; human factors; medication errors; perioperative period; survey

Mesh:

Substances:

Year:  2018        PMID: 30600135     DOI: 10.1016/j.jopan.2018.08.005

Source DB:  PubMed          Journal:  J Perianesth Nurs        ISSN: 1089-9472            Impact factor:   1.084


  1 in total

1.  Physicians' Attitude towards Electronic Medical Record Systems: An Input for Future Implementers.

Authors:  Mulugeta Hayelom Kalayou; Berhanu Fikadie Endehabtu; Habtamu Alganeh Guadie; Zeleke Abebaw; Kassahun Dessie; Shekur Mohammed Awol; Nebyu Demeke Mengestie; Abraham Yeneneh; Binyam Tilahun
Journal:  Biomed Res Int       Date:  2021-08-28       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.